Healthcare Services Group, Inc. — Q3 2022 Form 10-Q
Business context and period: The company provides housekeeping, laundry, linen, facility-maintenance and dietary services to U.S. healthcare facilities, primarily long-term-care providers. This unaudited report covers the quarter and nine months ended September 30, 2022. Results are not necessarily indicative of future periods.
Financial performance
| Metric | Q3 2022 | Q3 2021 | Nine months 2022 | Nine months 2021 |
|---|---|---|---|---|
| Revenue | $414.5 million | $415.6 million | $1,266.2 million | $1,221.5 million |
| Income before taxes | $1.0 million | $12.1 million | $25.0 million | $60.1 million |
| Net income | $0.3 million | $9.5 million | $18.5 million | $43.8 million |
| Diluted EPS | $0.00 | $0.13 | $0.25 | $0.58 |
| Operating cash flow | Not stated for quarter | Not stated for quarter | $(31.1) million | $5.7 million |
Margins and costs: Costs of services were 90.9% of revenue in Q3, versus 87.8% a year earlier; pretax margin was 0.3%, versus 2.9%. For the nine months, service costs were 89.2% of revenue, versus 85.0%, and net margin was 1.5%, versus 3.6%. Management attributed pressure primarily to inflation in labor and supplies, as well as a $10.0 million customer variable-consideration resolution that reduced revenue.
Segments: Q3 Housekeeping revenue fell 3.2% to $196.9 million, while Dietary revenue rose 2.5% to $217.5 million. Dietary’s Q3 costs exceeded segment revenue (100.2% of revenue), and the segment recorded a $0.4 million pretax loss. For the first nine months, Housekeeping revenue declined 3.8% to $597.7 million and Dietary revenue increased 11.4% to $668.4 million. Nine-month pretax income declined in both segments: Housekeeping to $55.8 million and Dietary to $19.3 million.
Cash, liquidity and debt
- Cash and cash equivalents were $19.6 million at September 30, 2022, down from $70.8 million at December 31, 2021. Cash plus marketable securities totaled $113.4 million, compared with $185.2 million.
- Working capital was $330.9 million; the current ratio was 2.8 to 1. Net operating cash use of $31.1 million reflected a $75.0 million increase in accounts and notes receivable and a $21.2 million decrease in accrued payroll.
- The company had $25.0 million outstanding on its $475 million line of credit. Outstanding letters of credit of $81.0 million reduced stated availability to $369.0 million. The facility expires December 21, 2023; the company reported compliance with its financial covenants.
- Dividends paid during the nine months totaled $47.4 million. Capital expenditures were $4.1 million through September; management estimated full-year 2022 spending of $5 million to $6 million.
Material changes, outlook and risks
- Nine-month bad-debt provision was $23.3 million, compared with $10.8 million a year earlier. Management cited aging receivables and a customer operating group entering receivership, which contributed an estimated $7.1 million increase. The allowance for doubtful accounts was $70.5 million at quarter-end.
- Nine-month investment and other expense was $9.0 million, versus $6.3 million of income in 2021, largely reflecting market losses on deferred-compensation investments. The company also reported $9.5 million of after-tax unrealized losses on available-for-sale securities in other comprehensive income.
- Management said labor shortages, wage growth, inflation, supply-chain disruption and below-target nursing-home occupancy continued to challenge operations. Commodity food prices and customer collection delays are additional concerns. The company expects to continue paying a regular quarterly dividend, but future payments are not assured.
- Management stated that existing cash, operating cash flows and credit capacity should meet foreseeable operating and growth needs. No specific revenue or earnings guidance was provided. It estimated 2022 capital expenditures at $5 million to $6 million.
- The company cited customer concentration, healthcare reimbursement and regulatory changes, COVID-19 effects, credit and collection risk, labor and supply costs, and geopolitical disruption including the Russia-Ukraine conflict as risks. Certain pending litigation losses cannot currently be reasonably estimated; the filing says their ultimate outcomes could affect results in a particular period.
- The filing identifies a previously disclosed SEC matter as concluded, with lower legal and professional fees compared with 2021. The filing also records the $10.0 million revenue reduction associated with resolution of variable consideration with an existing customer.
Investor verification priorities
- Review subsequent receivable aging, customer collections, allowance adequacy and the financial condition of the customer group in receivership.
- Assess whether labor, supply and food-cost inflation can be offset through pricing, staffing efficiencies or other cost actions, particularly in Dietary.
- Track operating cash flow, liquidity and line-of-credit borrowings, including the impact of dividends and required insurance letters of credit.
- Examine the effect of the $10.0 million customer adjustment and other variable-consideration estimates on reported revenue and segment trends.
- Monitor the status and potential financial effects of pending legal, tax and regulatory matters, which the filing does not quantify clearly.